A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 59,707 shares of TEVA stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,707
Previous 64,703 7.72%
Holding current value
$1.02 Million
Previous $1.05 Million 2.28%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$15.81 - $18.96 $78,986 - $94,724
-4,996 Reduced 7.72%
59,707 $1.08 Million
Q2 2024

Jul 19, 2024

SELL
$12.78 - $17.4 $5,278 - $7,186
-413 Reduced 0.63%
64,703 $1.05 Million
Q1 2024

Apr 22, 2024

SELL
$10.67 - $14.43 $83,332 - $112,698
-7,810 Reduced 10.71%
65,116 $918,000
Q4 2023

Jan 16, 2024

SELL
$8.12 - $10.63 $6,390 - $8,365
-787 Reduced 1.07%
72,926 $761,000
Q3 2023

Oct 24, 2023

SELL
$7.48 - $10.7 $5,804 - $8,303
-776 Reduced 1.04%
73,713 $751,000
Q2 2023

Jul 25, 2023

SELL
$7.2 - $9.47 $135,180 - $177,799
-18,775 Reduced 20.13%
74,489 $560,000
Q1 2023

Apr 14, 2023

SELL
$8.36 - $11.37 $47,351 - $64,399
-5,664 Reduced 5.73%
93,264 $825,000
Q4 2022

Feb 08, 2023

SELL
$7.95 - $9.48 $11,654 - $13,897
-1,466 Reduced 1.46%
98,928 $902,000
Q3 2022

Oct 25, 2022

SELL
$6.86 - $11.95 $175,609 - $305,908
-25,599 Reduced 20.32%
100,394 $810,000
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $72,752 - $102,523
9,858 Added 8.49%
125,993 $947,000
Q1 2022

May 11, 2022

BUY
$7.33 - $9.39 $61,058 - $78,218
8,330 Added 7.73%
116,135 $1.09 Million
Q4 2021

Feb 08, 2022

SELL
$7.9 - $10.19 $347,244 - $447,901
-43,955 Reduced 28.96%
107,805 $864,000
Q3 2021

Nov 02, 2021

SELL
$8.38 - $10.18 $1.27 Million - $1.55 Million
-152,111 Reduced 50.06%
151,760 $1.48 Million
Q2 2021

Aug 11, 2021

SELL
$9.9 - $11.56 $2.87 Million - $3.36 Million
-290,358 Reduced 48.86%
303,871 $3.01 Million
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $270,845 - $335,545
26,194 Added 4.61%
594,229 $6.86 Million
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $136,253 - $174,708
15,825 Added 2.87%
568,035 $5.48 Million
Q3 2020

Nov 04, 2020

BUY
$8.57 - $12.69 $538,041 - $796,703
62,782 Added 12.83%
552,210 $4.98 Million
Q2 2020

Jul 17, 2020

BUY
$8.12 - $13.12 $205,265 - $331,660
25,279 Added 5.45%
489,428 $6.04 Million
Q1 2020

Apr 21, 2020

BUY
$6.69 - $13.45 $695,010 - $1.4 Million
103,888 Added 28.84%
464,149 $4.17 Million
Q4 2019

Feb 12, 2020

BUY
$6.53 - $10.72 $828,239 - $1.36 Million
126,836 Added 54.34%
360,261 $3.53 Million
Q3 2019

Nov 07, 2019

SELL
$6.16 - $9.6 $52,544 - $81,888
-8,530 Reduced 3.53%
233,425 $1.61 Million
Q2 2019

Aug 06, 2019

BUY
$8.12 - $15.72 $1.48 Million - $2.87 Million
182,523 Added 307.11%
241,955 $2.23 Million
Q1 2019

May 06, 2019

SELL
$15.58 - $20.01 $261,042 - $335,267
-16,755 Reduced 21.99%
59,432 $932,000
Q4 2018

Feb 11, 2019

BUY
$14.59 - $23.84 $21,841 - $35,688
1,497 Added 2.0%
76,187 $1.18 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $184,969 - $225,283
-8,783 Reduced 10.52%
74,690 $1.61 Million
Q2 2018

Jul 30, 2018

BUY
$16.77 - $24.71 $284,184 - $418,735
16,946 Added 25.47%
83,473 $2.03 Million
Q1 2018

Apr 16, 2018

SELL
$16.68 - $22.07 $33,877 - $44,824
-2,031 Reduced 2.96%
66,527 $1.14 Million
Q4 2017

Feb 09, 2018

SELL
$11.23 - $19.1 $84,449 - $143,632
-7,520 Reduced 9.88%
68,558 $1.3 Million
Q3 2017

Oct 26, 2017

SELL
$15.41 - $32.17 $1.29 Million - $2.69 Million
-83,555 Reduced 52.34%
76,078 $1.34 Million
Q2 2017

Aug 15, 2017

BUY
N/A
159,633
159,633 $5.3 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.